amikacin has been researched along with Pleurisy, Tuberculous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blackmore, T; McNaughton, A; McNaughton, H | 1 |
Charoenlap, P; Limthongkul, S; Nuchprayoon, C; Songkhla, YN; Udompanich, V | 1 |
2 other study(ies) available for amikacin and Pleurisy, Tuberculous
Article | Year |
---|---|
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand.
Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 2016 |
The pathogenesis of low glucose concentrations in acidotic pleural fluid of tuberculous effusions.
Topics: Acidosis; Amikacin; Biological Transport; Blood Glucose; Blood Urea Nitrogen; Carbon Dioxide; Glucose; Humans; Hydrogen-Ion Concentration; Oxygen Consumption; Pleural Effusion; Tuberculosis, Pleural | 1988 |